Characterization of a Cytotoxic Transglutaminase from Mycobacterium spp. Driving RIPK1 Activation
Bulletin of Pioneering Researches of Medical and Clinical Science · 2024 · 4 (2) · 167-176
DOI: 10.51847/cgqobhs5ci ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin of Pioneering Researches of Medical and Clinical Science, 2024. Verfasst von Claire Martin und 3 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Martin, C., Robert, J., Bernard, S., & Girard, A. (2024). Characterization of a Cytotoxic Transglutaminase from Mycobacterium spp. Driving RIPK1 Activation. Bulletin of Pioneering Researches of Medical and Clinical Science, 4(2), 167-176. https://doi.org/10.51847/cgqobhs5ci
Vancouver
Martin C, Robert J, Bernard S, Girard A. Characterization of a Cytotoxic Transglutaminase from Mycobacterium spp. Driving RIPK1 Activation. Bulletin of Pioneering Researches of Medical and Clinical Science. 2024;4(2):167-176. doi:10.51847/cgqobhs5ci
BibTeX
@article{Martin2024,
author = {Martin, Claire and Robert, Julien and Bernard, Sophie and Girard, Antoine},
title = {Characterization of a Cytotoxic Transglutaminase from Mycobacterium spp. Driving RIPK1 Activation},
journal = {Bulletin of Pioneering Researches of Medical and Clinical Science},
year = {2024},
volume = {4},
number = {2},
pages = {167--176},
doi = {10.51847/cgqobhs5ci}
}
EUVIMED